BACKGROUND: Oral tongue cancer incidence has increased among whites in the United States; however, the cause remains unknown. If an infectious agent is implicated, then elevated risk would be expected among immunosuppressed individuals. METHODS: By using population-based registry linkage information from the US Transplant Cancer Match and human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) Cancer Match studies, the authors examined the risk of oral tongue squamous cell carcinoma (SCC) among immunocompromised transplantation recipients and HIV-infected individuals. In addition, the risks of oropharyngeal SCC (strongly related to human papillomavirus infection; modestly affected by immunosuppression), other tobacco/alcohol-related oral cavity SCCs (not thought to be infection/immunosuppression-related), and non-Hodgkin lymphoma of oral cavity/pharynx (strongly related to Epstein-Barr virus; profoundly affected by immunosuppression) were evaluated. RESULTS: Compared with the general population, the risk of non-Hodgkin lymphoma was strongly increased (standardized incidence ratio [SIR] > 8.0). The risk of all SCCs was modestly and similarly elevated among transplantation recipients (SIR range, 2.2-2.7; P heterogeneity 5.2); whereas, among HIV-infected individuals, the risk of oral tongue SCC was higher compared with the risk of other SCCs (SIR, 3.0 vs 1.7 [for oropharyngeal SCCs] and 2.3 [for other oral cavity SCCs]; P heterogeneity <.001). The risk of SCCs was significantly higher among men, older individuals, and whites; and risk increased with the time since transplantation/AIDS onset. The risk of oral tongue SCC was significantly higher among HIV-infected men who have sex with men compared with the average risk in HIV-infected individuals (adjusted incidence rate ratio 5 2.0). CONCLUSIONS: Similar modest increases in the risk of oral tongue and other oral cavity SCCs do not suggest that an infectious agent or exposure profoundly affected by immunosuppression underlies the increase in oral tongue cancer.
INTRODUCTION
Reduction in tobacco use in recent years has led to appreciable declines in the incidence of most oral cavity cancers in the United States.
1-3 By contrast, the incidence of oral tongue cancer (involving the anterior two-thirds of the tongue) has increased significantly during the same calendar era among young, white adults in the United States. [3] [4] [5] [6] Similar increases in oral tongue cancer incidence have occurred in Nordic countries. 7 The reasons for this increase in oral tongue cancer incidence, however, remain unknown. The discovery that human papillomavirus (HPV) infection is responsible for a similar recent increase in oropharyngeal cancer suggests that a virus may underlie the rise in oral tongue cancer as well. 2, 8 However, prior studies suggest that HPV does not play a major etiologic role in the development of oral cavity cancers, including oral tongue cancer. [9] [10] [11] [12] Furthermore, modestly sized molecular studies have not identified known viral transcripts in oral tongue tumors. 12, 13 Epidemiologic investigations of cancer risk in immunosuppressed populations have played an important role in understanding infectious etiologies of cancer. Indeed, risks of many virally induced cancers (eg, Kaposi sarcoma caused by Kaposi sarcoma-associated herpesvirus, nonHodgkin and Hodgkin lymphoma caused by Epstein-Barr virus [EBV] , cervical and other anogenital cancers caused by HPV) are elevated among immunosuppressed populations, including transplantation recipients and human immunodeficiency virus (HIV)-infected individuals. 14, 15 Furthermore, the discovery of an elevated risk of Merkel cell carcinoma among immunosuppressed patients with acquired immune deficiency syndrome (AIDS) 16 motivated investigators to search for a viral etiology, leading to the identification of Merkel cell polyomavirus. 17 We hypothesized that a virus may cause oral tongue cancer. If so, we would expect an elevated risk among immunosuppressed populations. To test our hypothesis, we evaluated the risk of oral tongue cancers in 2 immunosuppressed populations-solid-organ transplantation recipients (within the Transplant Cancer Match [TCM] study) and HIVinfected individuals (within the HIV/AIDS Cancer Match [HACM] study). 14, 15, 18 Transplantation recipients become immunosuppressed because of the use of medications to prevent organ rejection; whereas among HIV-infected individuals, the virus causes progressive depletion of CD4 T-cells that eventually leads to AIDS (or advanced HIV). Both groups have a similarly high risk of opportunistic infections and a high risk of cancers caused by viruses. 14, 15 To guide interpretation of our results, we exploited the etiologic similarities and differences across head-andneck cancer anatomic and histologic subtypes. Specifically, we compared patterns in the risk of oral tongue cancers in immunosuppressed individuals with the risk of HPV-related oropharyngeal squamous cell carcinomas (SCCs) (cancers caused by HPV and modestly associated with immunosuppression), oral cavity/pharynx nonHodgkin lymphoma (NHL) (caused by EBV and profoundly affected by immunosuppression), and oral cavity SCC (tobacco/alcohol-related, without known infectious origin or associations with immunosuppression).
MATERIALS AND METHODS

Participants and Cancer Outcomes
We used data from the ongoing TCM study 14 (available at: http://transplantmatch.cancer.gov, accessed March 14, 2018 ) and the HACM study 15, 18 (available at: http://www. hivmatch.cancer.gov, accessed March 14, 2018) , which link population-based cancer registries with the US Scientific Registry of Transplant Recipients (SRTR) or state HIV registries. Methods for both studies have previously been described and are briefly summarized below. 14, 15, 18 In the TCM study, information from the SRTR was available from 1987 through 2012, with linkage to 16 US state/metropolitan area cancer registries. The SRTR provides complete ascertainment of all US solid-organ transplantation recipients and includes patient characteristics as well as indication for transplantation. Only recipients residing in 1 of the participating cancer registry regions were eligible for inclusion. Follow-up began at the later of time of transplantation or start of cancer registry coverage and ended at the earliest occurrence of death, failure of transplanted organ or retransplantation, loss to follow-up by the transplant registry, or end of cancer registry coverage.
In the HACM study, we restricted our analysis to HIV-infected individuals in 8 US states and Puerto Rico after the introduction of highly active antiretroviral therapy (ie, 1996-2012). Follow-up began at the later of time of HIV report/AIDS diagnosis or start of cancer registry coverage and ended at the earliest occurrence of death or the end of cancer registry coverage. For patients with available information, we analyzed data on CD4 counts, which were obtained from the HIV registries for the 12 months preceding cancer but closest to cancer diagnosis. Ethics approval was obtained from human subjects' research review committees, as required at the National Cancer Institute, and from institutional review boards of participating registries.
Incident invasive cancers (including oral tongue SCC, oropharyngeal SCC, other oral cavity SCC, and oral cavity/pharynx NHL) were identified using linked cancer registry data, and appropriate International Classification of Diseases for Oncology, Third Edition topography/histology codes (Supporting Table 1 ).
Statistical Analysis
Analyses were conducted separately for transplantation recipients and HIV-infected individuals. The risk of each of the 4 head-and-neck cancer sites among transplantation recipients and in HIV-infected individuals relative to the general population was quantified through the calculation of standardized incidence ratios (SIR). The SIR was calculated as the ratio of the observed to the expected number of cancers in the general population, with corresponding exact 95% Poisson confidence intervals (CIs). The expected numbers of cancers in each study were calculated by applying cancer rates from the respective cancer registries (stratified by age, sex, race/ethnicity, and calendar year) to person-time at risk among HIV-infected individuals or transplantation recipients.
We hypothesized that quantitative similarities in SIRs for oral tongue cancer and NHL would point to a likely infectious etiology that would be profoundly affected by immunosuppression. If we observed similarities for SIRs across oral tongue and other oral cavity cancers, and if these SIRs were substantially lower than those for NHL and oropharyngeal SCC, then the implication would be that the etiology of oral tongue cancer is not profoundly affected by immunosuppression. Finally, if oral tongue cancer SIRs were similar to those for oropharyngeal cancer, then our interpretation would be that there might be a viral etiology that is modestly impacted by immunosuppression. We statistically compared the SIRs for oral tongue cancer with those for oropharyngeal and other oral cavity SCCs (excluding oral cavity/pharyngeal NHL) using a Wald P value for heterogeneity.
Within the cohorts of transplantation recipients and HIV-infected individuals, we also investigated risk factors for each of the 4 cancers using multivariate Poisson regression. In the TCM study, we assessed incidence rate ratios (IRRs) for transplantation-related characteristics, including the number of years since transplantation, the transplanted organ, the receipt of specific immunosuppressive medications, and the degree of human leukocyte antigen (HLA) mismatch. For liver transplantation recipients, we separately compared the risk in those with and without alcoholic cirrhosis as the indication for transplantation. Because of heavy alcohol use, this group may be expected to have a greater risk of head-and-neck SCCs. 19 In the HACM study, IRRs were evaluated according to HIV risk group, time since AIDS onset, and attained calendar year. For variables without a natural referent group (transplanted organ in the TCM study and HIV risk group in the HACM study), effect parameterization was applied in which each level of the variable was compared with the average over all levels. P values for assessment of heterogeneity or trend also were calculated. All statistical tests were 2-sided, and P values < .05 were considered statistically significant.
RESULTS
Characteristics of 242,022 solid-organ transplantation recipients and 465,429 HIV-infected individuals in the TCM and HACM studies are presented in Table 1 . In the TCM study, most transplantation recipients were men (61%), white (61%), and aged <50 years at the time of transplantation (53%). Kidney (grouped in the table with pancreas) was the most common transplanted organ (58%), and most transplants occurred after 1996 (82%). In the HACM study, approximately one-half (52%) of participants had been diagnosed with AIDS at the start of follow-up. A large proportion of HACM participants Compared with the general US population, the incidence of all specified head-and-neck cancers was significantly elevated in transplantation recipients ( Table 2 ). The highest SIR was observed for oral cavity/pharynx NHL (SIR, 8.2; 95% CI, 6.0-10.8), whereas estimates for all other sites were lower and similar in magnitude (oral tongue SCC: SIR, 2.3; 95% CI, 1.6-3.2; oropharyngeal SCC: SIR, 2.2; 95% CI, 1.9-2.5; other oral cavity SCC: SIR, 2.7; 95% CI, 2.1-3.3; P heterogeneity 5 .2) ( Table 2) .
Among HIV-infected individuals, we observed 70 oral tongue SCCs, 311 oropharyngeal SCCs, 117 oral cavity SCCs, and 144 oral cavity/pharynx NHLs. The incidence of all specified head-and-neck cancers also was significantly elevated among individuals who had HIV, with the largest increase again observed for those with oral cavity/pharynx NHL (SIR, 12.4; 95% CI, 10.5-14.6) ( Table 2) . Notably, the risk of oral tongue SCC (SIR, 3.0; 95% CI, 2.3-3.8) was significantly elevated compared with that of oropharyngeal SCC (SIR, 1.7; 95% CI, 1.5-1.9) or other oral cavity SCC (SIR, 2.3; 95% CI, 1.9-2.8; P heterogeneity < .001) ( Table 2 ). Exclusion of the MSM HIV risk group, which accounted for one-half of oral tongue SCCs but a smaller proportion of other cancers, resulted in a reduced SIR for oral tongue SCC (SIR, from 3.0 to 2.5) that was more similar to the SIRs for oropharyngeal SCC (SIR, 2.1) and other oral cavity SCC (SIR, 2.4). The box plot in Figure 1 illustrates 3 for oral cavity/pharynx NHLs. Among transplantation recipients, the risk of oral tongue SCC was similar across sex and race, and it increased with age and time since transplantation (Table 3) . By contrast, the risk of oropharyngeal SCC, other oral cavity SCC, and oral cavity/pharynx NHL was significantly higher in men compared with women and among whites compared with other races. An elevated risk of oral tongue and other SCCs was observed among liver recipients whose indication for transplantation was alcoholic cirrhosis (oral tongue: IRR, 3.3; 95% CI, 1.5-7.5; oropharyngeal: IRR, 4.8; 95% CI, 3.4-6.7; other oral cavity: IRR, 5.5; 95% CI, 3.4-8.8). We observed no significant difference in risk for any cancer according to the use of specific immunosuppressive medications or HLA-mismatch status (results not shown). Among HIV-infected individuals, the risk of oral tongue SCC was similar across sex and calendar period, but it was higher among whites compared with other races and increased with age and time since AIDS onset (Table  4) . We also observed a significantly elevated risk of oral tongue SCC among MSM compared with the average across HIV risk groups (IRR, 2.0; 95% CI, 1.2-3.4). The risk of oropharyngeal SCC, other oral cavity SCC, and oral cavity/pharynx NHL was significantly higher in men compared with women, in whites compared with other races (except for other oral cavity SCC), and increased with age (except for oral cavity/pharynx NHL) and time since AIDS onset (except for oral cavity/pharynx NHL). In contrast, the risk of oral cavity/pharynx NHL significantly declined with time since AIDS onset and over calendar year period.
DISCUSSION
We investigated the risk of oral tongue cancer as well as other head-and-neck cancers in 2 immunosuppressed populations-transplantation recipients and individuals with HIV-to address whether oral tongue cancers might have a potential infectious etiology. We observed that the risk of oral tongue, other oral cavity, and oropharyngeal SCCs was modestly elevated among immunosuppressed individuals compared with the general US population. Among individuals with HIV, the risk of oral tongue SCC, although still modest, was significantly higher compared with that of other SCCs. Conversely, the risk of NHL of the oral cavity/pharynx was greatly elevated in immunosuppressed individuals, consistent with the known profound effect of immunosuppression on EBVassociated NHL.
These results suggest that the etiology underlying oral tongue SCC, similar to that of oropharyngeal and other oral cavity SCCs, is not greatly impacted by immunosuppression. The similarity in the magnitude of the risk of these cancers among immunosuppressed individuals compared with the general population points to the potential role of tobacco and alcohol, which are established risk factors for all head-and-neck SCCs. Although the prevalence of smoking is not known to be elevated Abbreviations: CI, confidence interval; IRR, incidence rate ratio; NE, not able to estimate; NHL, non-Hodgkin lymphoma; SCC, squamous cell carcinoma. a IRRs were adjusted for sex (categorical) and age (continuous), but not for the variables sex (adjusted for age only) and age (adjusted for sex only). b P values were obtained from the assessment of heterogeneity or trend (trend variables were age and years since transplantation). c Effect parameterization was applied in which each level was compared with the average overall level.
among solid-organ transplantation recipients compared with the general population, the prevalence of smoking as well as heavy alcohol consumption is elevated among individuals with HIV in the United States. [20] [21] [22] Supporting a role for alcohol in these head-and-neck SCCs, in our study, risk was notably high among liver transplantation recipients who had alcoholic cirrhosis.
Oropharyngeal SCCs are strongly associated with HPV infection, and it is known that the risk of these cancers is significantly elevated in immunosuppressed individuals compared with the general population, 23 albeit not to the same extent as the elevation in risk for other HPV-associated cancers (eg, cervical or anal cancer). 24, 25 Our observation that the SIR for oral tongue SCCs was statistically similar to the SIR for oropharyngeal SCCs in transplantation recipients and was marginally higher in HIV-infected individuals suggests a similar etiology for oral tongue cancers. Nevertheless, HPV is not believed to play a major etiologic role in oral tongue carcinogenesis, and recent sequencing studies of limited sample sizes have failed to identify known viral transcripts in oral tongue tumors, arguing against an etiologic role for HPV or another virus. 12, 13 Notwithstanding these results, the risk of oral tongue SCC was notably elevated in MSM compared with other HIV risk groups. This elevated risk accounted in part for the marginally higher risk of oral tongue SCCs versus other SCCs in HIV-infected individuals. One-half of all oral tongue SCCs among HIV-infected individuals occurred in the MSM risk group. By comparison, MSM accounted for 23% of oropharyngeal SCCs, 32% of other oral cavity SCCs, and 30% of oral cavity/pharynx NHLs. Although the precise reasons are unknown, these observations suggest a possible role of an exposure more common in MSM as the potential cause of the notable increase in the risk of oral tongue SCC among MSM. The modest, 2-fold to-3-fold increase in the risk of head-and-neck SCCs among transplantation recipients and HIV-infected individuals argues against a large effect of immunosuppression in the etiology of these cancers. Nonetheless, our observation that the risks of oral tongue, oropharyngeal, and other oral cavity SCCs significantly increased with markers of long-term immunosuppression, such as time since AIDS onset and time since transplantation, suggests a more subtle role for chronic immunosuppression. For example, it is possible that immunosuppression may alter the oral microbiome or nutritional status of an individual. In contrast, the risk of NHL is highest immediately after transplantation and at the time of AIDS onset, when the most intensive immunosuppression is present.
Because not all HIV-infected individuals are severely immunosuppressed, particularly in the highly active antiretroviral therapy (HAART) era, we also evaluated CD4 counts for a subset of HIV-infected patients with headand-neck cancer who had available information. Our results suggest that in the time interval closest to cancer diagnosis, individuals with oral tongue, oropharyngeal, and other oral cavity SCCs were moderately immunosuppressed, whereas those with oral cavity/pharynx NHLs were severely immunosuppressed. Also, although it is known that HAART has significantly improved the immune status of patients with HIV/AIDS, compared with the general population, risks remain elevated for those who have cancers profoundly affected by immunosuppression (eg, Kaposi sarcoma and NHL) along with the risks of cancers modestly affected by immunosuppression (eg, anal cancer). 26 These observations indicate that HAART-associated immune restoration is incomplete, at least as it pertains to the risk of certain cancers. Finally, the observation that the risks of cancer in our study were associated with time since AIDS onset further points to an effect of long-term immunosuppression in the etiology of these cancers.
There are strengths and limitations to our study. Although the large populations allowed us to assess cancer risk for HIV and transplantation groups overall, oral cavity/pharynx cancers are uncommon, and analyses for subgroups were limited for some comparisons. We assumed that the cause of a large proportion of oropharyngeal SCCs was HPV and that other oral cavity SCCs were caused by tobacco and alcohol use; however, we did not have information on HPV status of tumors or these lifestyle behaviors and thus could not assess these exposures in relation to patients with cancer in our study. There is also the possibility that chance associations arose because of multiple comparisons.
The factors contributing to the rise in oral tongue cancer among white men and women in the United States and other countries are uncertain. The modest SIRs in our study suggest that the rising incidence is unlikely to be a viral infection (like EBV) or other condition that is profoundly affected by immunosuppression. However, the elevated risk among HIV-infected MSM and the time since AIDS onset suggest that, like oropharyngeal cancer, oral tongue cancer may be caused by a sexually transmitted virus that is under more complex immune control (similar to HPV). Additional studies are needed to evaluate the risk factors that have increased over time and may be contributing to the increase in oral tongue cancer. 
